View Article

Abstract

Diabetes mellitus is a long-term disease that happens when the pancreas does not make enough insulin, or when the body cannot use the insulin properly. More than 415 million people in the world have diabetes, and this number may reach 642 million by 2040. The World Health Organization (WHO) says that by 2030, diabetes will be the seventh leading cause of death. Most people with diabetes are treated with insulin injections or tablets, but these treatments are sometimes hard for patients to follow regularly. In recent years, scientists have started focusing on transdermal systems – special patches or devices that deliver medicine through the skin. These systems have many benefits compared to injections and tablets. Studies show that medicines given through the skin are better absorbed because they do not pass through the liver first. They also release the medicine slowly over time, which helps keep blood sugar levels steady and reduces the need to take medicine many times a day. This makes it easier for patients to follow their treatment and improves their overall health. In short, using skin patches for diabetes treatment is a new and promising method that can make diabetes control easier and more effective.

Keywords

Transdermal, Diabetes, Antidiabetic, Insulin, Drug delivery system

Introduction

Diabetes mellitus is a long-term illness where the amount of sugar (glucose) in the blood becomes too high. This happens because the body does not make enough insulin. If diabetes is not treated, it can cause serious health problems like stroke, heart disease, or even death. Type 2 diabetes is more common than type 1. About 425 million people in the world have diabetes. According to the World Health Organization (WHO), diabetes cases have gone up to 4.7%, and it may become the seventh biggest cause of death in the world by 2030.Insulin is very important to control diabetes. In type 1 diabetes, the body’s cells that make insulin (called beta cells) are destroyed, so no insulin is made. In type 1A diabetes, this happens because the immune system attacks these cells. Type 1B (idiopathic diabetes) happens when beta cells are lost, but the cause is unknown. Type 2 diabetes is usually linked to family history, lifestyle, and environment. Gestational diabetes happens during pregnancy when the body makes less insulin, which raises blood sugar levels1.Type 1 diabetes (T1DM) happens when the beta cells in the pancreas (found in the islets of Langerhans) are destroyed. These cells make insulin, so their loss causes a complete lack of insulin in the body. Type 1A diabetes, also called insulin-dependent diabetes, is caused by the immune system attacking and destroying the beta cells. The speed of destruction can be different for different people. Type 1B diabetes, or idiopathic diabetes, is when beta cells are lost but there is no clear immune system attack or other known reason for insulin deficiency2.

Reference

  1. Zhang Y, Yu J, Kahkoska AR, Wang J, Buse JB, Gu Z. Advances in transdermal insulin delivery. Adv. Drug Deliv Rev. 2019;139: 51–70.
  2. Srinivasan S, Elumalai K, Cherian BV, Ramanujam SK. Formulation and characterization of metformin hydrochloride orodispersible tablets with super disintegrants. Intelligent Pharm. 2023. https://doi.org/10.1016/j.ipha.2023.06.006.
  3. Ng LC, Gupta M. Transdermal drug delivery systems in diabetes management: a review. Asian J Pharm Sci. 2020;15(1):13–25.
  4. Singh S, Kushwaha P, Gupta SK. Exploring the potential of traditional herbs in the management of diabetic retinopathy: an overview. Drug Res. 2020;70(7):298–309.
  5. Sattley M. The history of diabetes: diabetes health; 2015. Available from: https://www.diabeteshealth.com/the-History-of-diabetes/.
  6. Lakhtakia R. The history of diabetes mellitus. SQUMJ2013;13(3):368–70.
  7. Barry BW. In, Dermatological Formulations: Percutaneous Absorption; 2ndEdn; Marcel Dekker, inc., New York, 1983, pp 1-39.
  8. Chein YW. In, Novel Drug Delivery Systems; 2ndEdn; Vol. 50, Marcel Dekker, New York, 1992, pp 301-381.
  9. Aulton ME. In, Pharmaceutics: The Science of Dosage Form Design; 1stEdn; Churchill Livingston, Edinburgh, 2002, pp 499-533.
  10. Anon, Transdermal delivery systems-general Drug release standards, Pharmacopeial Forum,1980; 14, 3860-3865.
  11. Finnin BC, Morgan TM, Transdermal penetration, J. Pharm. Sci.1999, 88(10), 955-958.
  12. Allen LV, Popovich NG, Ansel HC. In, Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems; 8thEdn; Lippincott Williams & Wilkins, Philadelphia, 2005, pp 298-315.
  13. Vyas SP, Khar RK. In, Controlled Drug Delivery: Concepts and Advances; 1stEdn; Vallabh Prakashan, 2002, pp 411-447.
  14. Fathima SA, Begum S, Fatima SS. Transdermal drug delivery system. IJPCR 2017;9(1):35–43.
  15. Yu WJ, Jiang GH, Liu DP, Li L, Tong ZZ, Yao JM, et al. Transdermal delivery of insulin with bioceramiccomposite microneedles fabricated by gelatin and hydroxyapatite. Mater Sci Eng C Mater Biol Appl 2017;73: 425–428.
  16. Seong KY, Seo MS, Hwang DY, O’Cearbhaill ED, Sreenan S, Karp JM, et al. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin. J Control Release 2017;265: 48–56.
  17. Yu W, Jiang G, Zhang Y, Liu D, Xu B, Zhou J. Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin. Mat Sci Eng: C 2017;80(SupplC):187–96.
  18. Zhang Y, Jiang G, Yu W, Liu D, Xu B. Microneedles fabricated from alginate and maltose for transdermal delivery of insulin on diabetic rats. Mat Sci Eng C 2018;85: 18–26.

Photo
Amin Shaikh
Corresponding author

Delight College of Pharmacy, Koregaon Bhima, Pune, Maharashtra, India-412216

Photo
Pratiksha Ravankole
Co-author

Delight College of Pharmacy, Koregaon Bhima, Pune, Maharashtra, India-412216

Photo
Priyanka Konde
Co-author

Delight College of Pharmacy, Koregaon Bhima, Pune, Maharashtra, India-412216

Photo
Fiza Mulani
Co-author

Delight College of Pharmacy, Koregaon Bhima, Pune, Maharashtra, India-412216

Amin Shaikh*, Pratiksha Ravankole, Priyanka Konde, Fiza Mulani, Transdermal Drug Delivery Systems in Diabetes Management: A Review, Int. J. Sci. R. Tech., 2025, 2 (9), 247-253. https://doi.org/10.5281/zenodo.17197138

More related articles
Review on Formulation of Herbal Gel Containing Ext...
Ravindra Hanwate, Sunil Sawale, Sneha Patekar, Sushmita Chavan, N...
Review on Fluconazole: Properties and Analytical Methods for its Determination...
Dnyaneshwari Gaikwad, Amol Gayke, Amol Jadhav, Komal Kute, ...
Herbal Plants in the Management of Dysbiosis: A Review of Mechanisms, Efficacy, ...
Sohail Shaikh, Pooja Rasal, Huzaifa Patel, Parth Khandelwal, Sanabil Shaikh, Saniya Shaikh, ...
Related Articles
Vigilant Eye: AI for Enhanced Visual Understanding...
Dipti Mehare, Rutuja Jogi, Janhvi Hiwe, Anjali Tamte, Vaishnavi Mahulkar, Sakshi Likhitkar, Sneha De...
Beyond Classical Categories: A Modern Taxonomic Framework for Brain Neurotransmi...
Arnab Roy, Nisha Kumari , Pratik Mondal , Ravi Kumar , Balraj Kumar , Dheeraj Prasad , Manish Kumar ...
A Review On: Microemulsion...
Prerana Jamdhade, Vaishnavi Dhage, Suvarna Sangale, Snehal Gondkar, Tanvir Pathan, Gursal Kanchan, ...